Leadership Overview
Zoetis has 10 executives leading key functions including technology, finance, marketing, and regional operations.
Driven by innovation in animal health, Zoetis is dedicated to discovering, developing, and commercializing medicines and vaccines that improve the health and well-being of animals worldwide, impacting both livestock and companion animals.
Driven by innovation in animal health, Zoetis is dedicated to discovering, developing, and commercializing medicines and vaccines that improve the health and well-being of animals worldwide, impacting both livestock and companion animals.
Leadership Roles at Zoetis
Lee Penn - Senior Director, Chief of Staff, Office of the Chief Executive Officer
Lee Penn, the Senior Director, Chief of Staff, Office of the Chief Executive Officer at Zoetis, provides strategic support and operational oversight to the CEO's office. This role involves managing key initiatives, facilitating cross-functional collaboration, and ensuring alignment across the executive leadership team. Penn's responsibilities include driving strategic projects, preparing executive communications, and optimizing the CEO's agenda to maximize impact on Zoetis's mission of advancing animal health. The Senior Director, Chief of Staff, Office of the Chief Executive Officer acts as a key liaison between the CEO and various departments, ensuring efficient execution of corporate strategies. Lee Penn's strategic counsel and operational management are critical for the effective functioning of the executive leadership and the company's overall direction.
Renato V. - Regional Chief Financial Officer, Latin America (Canada)
Renato V., the Regional Chief Financial Officer, Latin America (Canada) at Zoetis, directs financial operations and strategic planning across key international markets. This executive oversees financial reporting, budgeting, and forecasting for the Latin America and Canada regions, ensuring fiscal discipline and driving profitable growth. The Regional Chief Financial Officer, Latin America (Canada) plays a crucial role in evaluating market opportunities, managing financial risks, and optimizing resource allocation to support Zoetis's commercial objectives in animal health. Renato V.'s financial acumen guides investment decisions in areas such as livestock and companion animal product development and market expansion. This leadership position is vital for maintaining financial health and supporting the company's global mission.
Renato Vilas Boas - Regional Chief Financial Officer, Latin America (Canada)
Renato Vilas Boas, the Regional Chief Financial Officer, Latin America (Canada) at Zoetis, manages comprehensive financial strategies and operations for the Latin America and Canada territories. This executive is responsible for financial planning, analysis, and reporting, ensuring robust fiscal management and supporting sustainable business growth. Vilas Boas drives financial performance by identifying cost efficiencies, optimizing capital allocation, and mitigating financial risks within these key markets. The Regional Chief Financial Officer, Latin America (Canada) collaborates with regional leadership to align financial objectives with the company's broader goals of developing and commercializing animal health solutions. Renato Vilas Boas's leadership ensures financial integrity and strategic resource deployment across diverse markets.
Karen Kok - President, Business Support To Region & Africa (APAC)
Karen Kok, the President, Business Support To Region & Africa (APAC) at Zoetis, leads strategic business support functions across the Asia-Pacific region and Africa. This executive focuses on enhancing operational effectiveness and driving growth through integrated business support services. Kok's leadership involves optimizing resource allocation, fostering cross-functional collaboration, and ensuring alignment with Zoetis's global mission to improve animal health. The President, Business Support To Region & Africa (APAC) plays a key role in navigating regional market dynamics and supporting the commercialization of animal health medicines and vaccines. Karen Kok's strategic oversight is essential for strengthening Zoetis's presence and impact in these diverse and growing markets.
Kelly Biondolillo - Executive Business Partner To CDTO and Group President for China, Brazil and Precision Animal Health
Kelly Biondolillo, the Executive Business Partner To CDTO and Group President for China, Brazil and Precision Animal Health at Zoetis, provides critical strategic and operational support to key executive leaders. This role involves managing complex projects, facilitating communication between executive functions, and ensuring the seamless execution of initiatives related to digital transformation, China, Brazil operations, and precision animal health. Biondolillo's responsibilities include coordinating efforts across diverse geographical and functional areas, driving efficiency, and supporting the strategic objectives of the Chief Digital and Technology Officer and the Group President. The Executive Business Partner To CDTO and Group President for China, Brazil and Precision Animal Health ensures alignment and effective implementation of critical business strategies. Kelly Biondolillo's support is vital for advancing Zoetis's innovation and market presence in key growth areas.
Stephanie Armstrong - Regional President, & Africa (Asia Pacific)
Stephanie Armstrong, the Regional President, & Africa (Asia Pacific) at Zoetis, directs the company's strategic vision and operational execution across the expansive Asia Pacific and Africa regions. This executive leads market development, commercial strategies, and business growth initiatives, ensuring Zoetis's animal health medicines and vaccines effectively reach diverse customer bases. Armstrong's leadership focuses on understanding and responding to regional market nuances, driving innovation, and fostering strong relationships with stakeholders. The Regional President, & Africa (Asia Pacific) oversees a broad portfolio of products for both livestock and companion animals. Stephanie Armstrong's strategic guidance is instrumental in expanding Zoetis's global footprint and impact in these vital territories.
Kumar Venugopal - Chief Technology Officer
Kumar Venugopal, the Chief Technology Officer at Zoetis, directs the company's overarching technology strategy and execution. This leadership role involves architecting scalable technology solutions that support Zoetis's global operations in discovering, developing, and commercializing animal health medicines and vaccines. Venugopal oversees the integration of advanced technologies across the organization, ensuring that digital infrastructure and innovation align with business objectives. The Chief Technology Officer drives the adoption of new platforms and tools to enhance operational efficiency and product development cycles. By focusing on robust technological frameworks, Kumar Venugopal ensures Zoetis maintains a competitive edge in the rapidly evolving animal health market, supporting both livestock and companion animal sectors through cutting-edge solutions.
Mark Chomow - Head Chief Technology Officer, Transformation & Portfolio Management
Mark Chomow, the Head Chief Technology Officer, Transformation & Portfolio Management at Zoetis, spearheads critical initiatives focused on modernizing the company's technology landscape and optimizing its product portfolio. This executive drives strategic transformation projects, ensuring that technology investments yield maximum business value and support Zoetis's mission to advance animal health. Chomow's responsibilities include evaluating and integrating new technologies, managing the technology portfolio for maximum impact, and fostering a culture of continuous improvement. The Head Chief Technology Officer, Transformation & Portfolio Management works closely with other technology leaders to align IT strategy with business goals, particularly in areas of vaccine and medicine development. Mark Chomow's leadership ensures Zoetis remains agile and innovative in its approach to global animal health challenges.
Michael Tao - Chief Information Officer, Greater (China, APAC)
Michael Tao, the Chief Information Officer, Greater (China, APAC) at Zoetis, directs the information technology strategy and operations across China and the Asia-Pacific region. This executive is responsible for implementing robust IT infrastructure, cybersecurity measures, and digital solutions that support Zoetis's business objectives in these critical markets. Tao oversees the deployment of technology to enhance operational efficiency, data management, and innovation in animal health product development and commercialization. The Chief Information Officer, Greater (China, APAC) ensures that regional IT functions align with global standards while addressing local market needs. Michael Tao's leadership drives technological advancement and operational excellence, crucial for Zoetis's growth and impact in the APAC region.
Gokce Tan - Chief Marketing Officer & Logistics Coordinator
Gokce Tan, the Chief Marketing Officer & Logistics Coordinator at Zoetis, orchestrates comprehensive marketing strategies and oversees critical logistics operations to drive market penetration for animal health products. This dual role involves developing innovative marketing campaigns that resonate with veterinarians, livestock producers, and retail outlets, while also ensuring the efficient and timely distribution of medicines and vaccines. Tan's responsibilities encompass market analysis, brand management, and supply chain optimization to meet global demand. The Chief Marketing Officer & Logistics Coordinator plays a pivotal part in connecting Zoetis's product portfolio with its target audiences. Gokce Tan's integrated approach ensures both strong market presence and seamless product delivery worldwide.
Explore Leadership Teams in Manufacturing
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is dedicated to addressing unmet patient needs by advancing scientific research, expanding access to quality medicines, and streamlining the delivery of treatments -from established generics to cutting-edge therapeutic solutions.
Company Leadership EB
YK
CS
AL
PCI Pharma Services is an integrated full service provider to companies in the global healthcare industry. They offer services including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage, and distribution. They are headquartered in Philadelphia, Pennsylvania with locations in the United States and Europe.
Company Leadership AF
KS


Established in 1978 and headquartered in London, Hikma Pharmaceuticals is a multinational pharmaceutical company that manufactures branded and non-branded generic and in-licensed pharmaceutical products.
Company Leadership

PB
TD
Merz is a privately held pharmaceutical company based in Frankfurt, Germany with affiliates across Europe, as well as the US, Canada, Mexico, Brazil, and Asia Pacific. The company is active in research, development, and distribution of innovative products in the areas of aesthetic medicine and neurologically induced movement disorders.
Company Leadership LP
KH
WF
CG